Strong Impact on Hemostasis in COVID-19 Patients Webinar
Beginning in 2020, a high incidence of DVT and PE was reported in COVID-19 patients, particularly in severe cases. In this talk, we will distinguish the laboratory features of COVID-19 coagulopathology.
- COVID-19 and Coagulopathy
- VTE
- Anticoagulant therapy
- Pathophysiology
- Thrombosis
- Coagulopathy and COVID-19
- covid-19 microthrombosis
- thromboinflammation covid-19
- thrombosis prophylaxis guidelines vte prophylaxis
- microclots with covid
- hypercoagulability of covid-19
